E2F3 and neoplasm: We next performed ChIP assays and found that HNRNPL bound to E2F3 promoter in tumor cell lines (10 ~ 20-fold changes), while there are merely 2 ~ 4-fold changes in ARPE-19 and SV-HUC-1 (Fig. 7a-c).